Calvin Sternick

Stock Analyst at JP Morgan

(2.14)
# 2,946
Out of 5,042 analysts
19
Total ratings
46.15%
Success rate
8.76%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $86.27
Upside: +27.51%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $35.37
Upside: +126.18%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $12.08
Upside: +123.51%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $217.01
Upside: -16.13%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $206.49
Upside: -60.77%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $153.06
Upside: +156.11%